161493-94-3 Usage
General Description
(1-Methyl-1H-imidazol-2-yl)methanamine hydrochloride is a chemical compound that is used as a pharmaceutical intermediate and in synthesis processes. It is a derivative of imidazole, a five-membered heterocyclic compound, and has a methyl group and an amino group attached to the imidazole ring. The hydrochloride salt form of this compound is water-soluble, making it suitable for use in various pharmaceutical formulations. It is commonly used in the synthesis of pharmaceutical drugs and as a building block for the preparation of new chemical entities. (1-METHYL-1H-IMIDAZOL-2-YL)METHANAMINE HYDROCHLORIDE has potential applications in the development of therapeutic agents and in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 161493-94-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,4,9 and 3 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 161493-94:
(8*1)+(7*6)+(6*1)+(5*4)+(4*9)+(3*3)+(2*9)+(1*4)=143
143 % 10 = 3
So 161493-94-3 is a valid CAS Registry Number.
InChI:InChI=1/C5H9N3.ClH/c1-8-3-2-7-5(8)4-6;/h2-3H,4,6H2,1H3;1H
161493-94-3Relevant articles and documents
2-(1H-INDAZOL-6-YLAMINO)-BENZAMIDE COMPOUNDS AS PROTEIN KINASES INHIBITORS USEFUL FOR THE TREATMENT OF OPHTALMIC DISEASES
-
Page 74, (2010/02/07)
Indazole compounds that modulate and/or inhibit the ophthalmic diseases and the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating ophthalmic diseases and cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma,rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
